Autres langues Hexima Limited

Actions

Marché Fermé - Australian S.E. Autres places de cotation 02:56:26 03/07/2024			Varia. 5j.	Varia. 1 janv.
0,011 ^AUD	-8,33 %		+10,00 %	-38,89 %

28/02	Hexima Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI
2023	Hexima Limited annonce la démission du Dr. Nicole Van Der Weerden en tant qu'administrateur	CI

Hexima Secures R&D Tax Rebate for Fiscal Year 2023	22/03
Hexima Changes Address	19/03
Hexima Limited Announces Change of Address	19/03
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Hexima Limited Announces the Resignation of Dr. Nicole Van Der Weerden as Director	29/11
Hexima Limited Appoints Phillip Hains as A Non-Executive Director	19/09/23
Hexima Limited Appoints Geoffrey Kempler as Managing Director	06/09/23
Hexima Limited Announces Executive Changes	06/09/23
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Hexima Limited Announces Resignation of Mr. Steven Skala as an Alternate Director	11/05/23
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23
Hexima Limited Declares Voting Results	31/01/23
Arovella Therapeutics Appoints COO	04/01/23
Hexima Acting CEO to Step Down	22/12/22
Nicole Van Der Weerden to Step Down as CEO of Hexima Limited	22/12/22
Hexima Receives AU$6 Million Tax Incentive Refund from Australian Taxation Office	14/12/22
Hexima Limited Receives Requisition Notice from Merchant Biotech Fund	14/12/22
Hexima Limited Announces Board Changes	04/12/22
10,150,000 Options of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	01/12/22
6,925,878 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	01/12/22

Aucun résultat pour cette recherche